490 related articles for article (PubMed ID: 31549998)
1. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
[No Abstract] [Full Text] [Related]
2. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
[TBL] [Abstract][Full Text] [Related]
4. Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.
Machens A; Lorenz K; Weber F; Dralle H
Horm Metab Res; 2022 Jan; 54(1):7-11. PubMed ID: 34758495
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.
Hirokawa M; Higuchi M; Suzuki A; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2020 Oct; 67(10):1071-1075. PubMed ID: 32595200
[TBL] [Abstract][Full Text] [Related]
6. The changing incidence of thyroid cancer.
Kitahara CM; Sosa JA
Nat Rev Endocrinol; 2016 Nov; 12(11):646-653. PubMed ID: 27418023
[TBL] [Abstract][Full Text] [Related]
7. Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up.
Ahtiainen V; Vaalavirta L; Tenhunen M; Joensuu H; Mäenpää H
Acta Oncol; 2020 Sep; 59(9):1064-1071. PubMed ID: 32603613
[No Abstract] [Full Text] [Related]
8. Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.
Hanley JP; Jackson E; Morrissey LA; Rizzo DM; Sprague BL; Sarkar IN; Carr FE
Thyroid; 2015 Jul; 25(7):812-22. PubMed ID: 25936441
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.
Bauer AJ
Endocrinol Metab Clin North Am; 2020 Dec; 49(4):589-611. PubMed ID: 33153669
[TBL] [Abstract][Full Text] [Related]
10. Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?
Oh CM; Lim J; Jung YS; Kim Y; Jung KW; Hong S; Won YJ
Cancer Med; 2021 Jun; 10(12):4087-4096. PubMed ID: 33979040
[TBL] [Abstract][Full Text] [Related]
11. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.
Rossi ED; Faquin WC; Pantanowitz L
Cancer Cytopathol; 2019 Jul; 127(7):432-446. PubMed ID: 31150164
[TBL] [Abstract][Full Text] [Related]
12. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
Simms A; Jacob RP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
Rendl G; Rodrigues M; Schweighofer-Zwink G; Hutter J; Hittmair A; Zellinger B; Hauser-Kronberger C; Pirich C
Wien Klin Wochenschr; 2017 Aug; 129(15-16):540-544. PubMed ID: 28493027
[TBL] [Abstract][Full Text] [Related]
14. Older patients with differentiated thyroid cancer exhibit more aggressive pathological characteristics than younger patients.
Johar J; Britton H; Wiseman SM
Can J Surg; 2020 Feb; 63(1):E69-E70. PubMed ID: 32031767
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort.
Chung R; Guan H; Ponchiardi C; Cerda S; Marwaha N; Yilmaz OH; Pinjic E; McAneny D; Lee SL; Drake FT
Thyroid; 2021 Jan; 31(1):68-75. PubMed ID: 32539676
[No Abstract] [Full Text] [Related]
16. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
Lubitz CC; Sadow PM; Daniels GH; Wirth LJ
Thyroid; 2021 Oct; 31(10):1451-1462. PubMed ID: 33860688
[No Abstract] [Full Text] [Related]
17. Papillary and Follicular Thyroid Cancer in children and adolescents: Current approach and future directions.
Bauer AJ
Semin Pediatr Surg; 2020 Jun; 29(3):150920. PubMed ID: 32571505
[TBL] [Abstract][Full Text] [Related]
18. Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.
Ali SZ; Siperstein A; Sadow PM; Golding AC; Kennedy GC; Kloos RT; Ladenson PW
Cancer Cytopathol; 2019 Jun; 127(6):362-369. PubMed ID: 31017745
[TBL] [Abstract][Full Text] [Related]
19. Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.
Ibrahimpasic T; Ghossein R; Shah JP; Ganly I
Thyroid; 2019 Mar; 29(3):311-321. PubMed ID: 30747050
[TBL] [Abstract][Full Text] [Related]
20. Histopathological profile of childhood thyroid carcinoma in Ibadan, Southwestern Nigeria.
Ajani MA; Omenai SA; Nwadiokwu JI; Salami AA
Malawi Med J; 2020 Dec; 32(4):213-217. PubMed ID: 34457206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]